Inclusion Criteria:  Age 18 and above Diagnosis of atopic dermatitis for ≥1 year Inadequate response to treatment with topical medications Confirmed dupilumab treatment  Exclusion Criteria:  Age below 18 Known or suspected allergy or reaction to any component of the dupilumab formulation Known active allergic or irritant contact dermatitis that is likely to interfere with the assessment of the severity of AD Severe conjunctivitis or blepharitis